vs
Side-by-side financial comparison of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) and R F INDUSTRIES LTD (RFIL). Click either name above to swap in a different company.
LIFECORE BIOMEDICAL, INC. \DE\ is the larger business by last-quarter revenue ($31.1M vs $22.7M, roughly 1.4× R F INDUSTRIES LTD). R F INDUSTRIES LTD runs the higher net margin — 0.8% vs -32.1%, a 32.9% gap on every dollar of revenue. On growth, R F INDUSTRIES LTD posted the faster year-over-year revenue change (22.9% vs -4.5%). R F INDUSTRIES LTD produced more free cash flow last quarter ($2.0M vs $25.0K). Over the past eight quarters, R F INDUSTRIES LTD's revenue compounded faster (29.8% CAGR vs -0.1%).
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
Tootsie Roll Industries is an American manufacturer of confectionery based in Chicago, Illinois. Its best-known products include the namesake Tootsie Rolls and Tootsie Pops. Tootsie Roll Industries currently markets its brands internationally in Canada, Mexico, and over 75 other countries.
LFCR vs RFIL — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $31.1M | $22.7M |
| Net Profit | $-10.0M | $173.0K |
| Gross Margin | 25.0% | 36.8% |
| Operating Margin | -9.9% | 4.0% |
| Net Margin | -32.1% | 0.8% |
| Revenue YoY | -4.5% | 22.9% |
| Net Profit YoY | -52.0% | 172.7% |
| EPS (diluted) | $-0.29 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $22.7M | ||
| Q3 25 | $31.1M | $19.8M | ||
| Q2 25 | — | $18.9M | ||
| Q1 25 | $35.2M | $19.2M | ||
| Q4 24 | $32.6M | $18.5M | ||
| Q3 24 | $24.7M | $16.8M | ||
| Q2 24 | — | $16.1M | ||
| Q1 24 | $35.7M | $13.5M |
| Q4 25 | — | $173.0K | ||
| Q3 25 | $-10.0M | $392.0K | ||
| Q2 25 | — | $-245.0K | ||
| Q1 25 | $-14.8M | $-245.0K | ||
| Q4 24 | $-6.6M | $-238.0K | ||
| Q3 24 | $-16.2M | $-705.0K | ||
| Q2 24 | — | $-4.3M | ||
| Q1 24 | $15.6M | $-1.4M |
| Q4 25 | — | 36.8% | ||
| Q3 25 | 25.0% | 34.0% | ||
| Q2 25 | — | 31.5% | ||
| Q1 25 | 28.0% | 29.8% | ||
| Q4 24 | 34.0% | 31.3% | ||
| Q3 24 | 21.8% | 29.5% | ||
| Q2 24 | — | 29.9% | ||
| Q1 24 | 33.3% | 24.5% |
| Q4 25 | — | 4.0% | ||
| Q3 25 | -9.9% | 3.6% | ||
| Q2 25 | — | 0.6% | ||
| Q1 25 | -25.7% | 0.3% | ||
| Q4 24 | -6.0% | 0.5% | ||
| Q3 24 | -46.9% | -2.5% | ||
| Q2 24 | — | -2.6% | ||
| Q1 24 | -2.5% | -15.5% |
| Q4 25 | — | 0.8% | ||
| Q3 25 | -32.1% | 2.0% | ||
| Q2 25 | — | -1.3% | ||
| Q1 25 | -42.0% | -1.3% | ||
| Q4 24 | -20.2% | -1.3% | ||
| Q3 24 | -65.7% | -4.2% | ||
| Q2 24 | — | -26.7% | ||
| Q1 24 | 43.8% | -10.1% |
| Q4 25 | — | $0.01 | ||
| Q3 25 | $-0.29 | $0.04 | ||
| Q2 25 | — | $-0.02 | ||
| Q1 25 | $-0.47 | $-0.02 | ||
| Q4 24 | $-0.25 | $-0.02 | ||
| Q3 24 | $-0.53 | $-0.07 | ||
| Q2 24 | — | $-0.41 | ||
| Q1 24 | $0.42 | $-0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.9M | $5.1M |
| Total DebtLower is stronger | $136.0M | — |
| Stockholders' EquityBook value | $-10.5M | $35.2M |
| Total Assets | $235.2M | $73.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $5.1M | ||
| Q3 25 | $18.9M | $3.0M | ||
| Q2 25 | — | $3.6M | ||
| Q1 25 | $5.4M | $1.3M | ||
| Q4 24 | $9.5M | $839.0K | ||
| Q3 24 | — | $1.8M | ||
| Q2 24 | — | $1.4M | ||
| Q1 24 | — | $4.5M |
| Q4 25 | — | — | ||
| Q3 25 | $136.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $124.9M | — | ||
| Q4 24 | $111.3M | — | ||
| Q3 24 | $106.3M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $97.1M | — |
| Q4 25 | — | $35.2M | ||
| Q3 25 | $-10.5M | $34.8M | ||
| Q2 25 | — | $34.2M | ||
| Q1 25 | $2.2M | $34.2M | ||
| Q4 24 | $15.4M | $34.1M | ||
| Q3 24 | $-3.9M | $34.1M | ||
| Q2 24 | — | $34.6M | ||
| Q1 24 | $17.7M | $38.7M |
| Q4 25 | — | $73.0M | ||
| Q3 25 | $235.2M | $73.2M | ||
| Q2 25 | — | $72.7M | ||
| Q1 25 | $237.7M | $70.4M | ||
| Q4 24 | $255.4M | $71.0M | ||
| Q3 24 | $246.8M | $71.9M | ||
| Q2 24 | — | $72.8M | ||
| Q1 24 | $246.2M | $79.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 56.05× | — | ||
| Q4 24 | 7.20× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 5.49× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.8M | $2.1M |
| Free Cash FlowOCF − Capex | $25.0K | $2.0M |
| FCF MarginFCF / Revenue | 0.1% | 9.0% |
| Capex IntensityCapex / Revenue | 5.6% | 0.3% |
| Cash ConversionOCF / Net Profit | — | 12.13× |
| TTM Free Cash FlowTrailing 4 quarters | $-16.8M | $4.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $2.1M | ||
| Q3 25 | $1.8M | $-311.0K | ||
| Q2 25 | — | $2.2M | ||
| Q1 25 | $1.2M | $601.0K | ||
| Q4 24 | $-6.1M | $-244.0K | ||
| Q3 24 | $-613.0K | $2.4M | ||
| Q2 24 | — | $197.0K | ||
| Q1 24 | $-1.4M | $840.0K |
| Q4 25 | — | $2.0M | ||
| Q3 25 | $25.0K | $-419.0K | ||
| Q2 25 | — | $2.2M | ||
| Q1 25 | $-4.3M | $574.0K | ||
| Q4 24 | $-8.6M | $-418.0K | ||
| Q3 24 | $-4.0M | $2.1M | ||
| Q2 24 | — | $28.0K | ||
| Q1 24 | $-7.8M | $697.0K |
| Q4 25 | — | 9.0% | ||
| Q3 25 | 0.1% | -2.1% | ||
| Q2 25 | — | 11.4% | ||
| Q1 25 | -12.1% | 3.0% | ||
| Q4 24 | -26.3% | -2.3% | ||
| Q3 24 | -16.3% | 12.6% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | -21.8% | 5.2% |
| Q4 25 | — | 0.3% | ||
| Q3 25 | 5.6% | 0.5% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | 15.5% | 0.1% | ||
| Q4 24 | 7.5% | 0.9% | ||
| Q3 24 | 13.9% | 1.5% | ||
| Q2 24 | — | 1.0% | ||
| Q1 24 | 17.8% | 1.1% |
| Q4 25 | — | 12.13× | ||
| Q3 25 | — | -0.79× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.09× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
RFIL
| US | $20.9M | 92% |
| Non Us | $1.8M | 8% |
